N James Topper
Affiliations
- at Mbx Biosciences Inc. (MBX), 2024-09-18
- Large Shareholder at Hillevax Inc. (HLVX), 2024-05-31
- at Phathom Pharmaceuticals Inc. (PHAT), 2024-05-24
- Director at Alpine Immune Sciences Inc. (ALPN), 2024-05-21
- at Newamsterdam Pharma Co N.v. (NAMS), 2024-03-28
- Large Shareholder at Arcutis Biotherapeutics Inc. (ARQT), 2023-10-26
- Large Shareholder, Director at Anaptysbio Inc (ANAB), 2023-01-11
- Chief Executive Officer at Frazier Lifesciences Acquisition Corp (FLAC), 2020-12-17
- Large Shareholder, Director at Allena Pharmaceuticals Inc. (ALNA), 2020-11-18
- Large Shareholder at Tarsus Pharmaceuticals Inc. (TARS), 2020-10-21
- Director at Aptinyx Inc. (APTX), 2020-04-02
- Large Shareholder at Passage Bio Inc. (PASG), 2020-03-03
- Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2020-01-13
- Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-24
- Large Shareholder, Director at Sierra Oncology Inc. (SRRA), 2017-02-16
- Large Shareholder at Glaukos Corp (GKOS), 2015-06-30
- Large Shareholder at Collegium Pharmaceutical Inc (COLL), 2015-05-14
- Director at Amicus Therapeutics Inc (FOLD), 2014-06-16
- Director at Portola Pharmaceuticals Inc (PTLA), 2013-06-07
- Director at La Jolla Pharmaceutical Co (LJPC), 2009-02-26
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| NAMS | $21.50 | 8,429 | 3,008,429 | 2024-03-26 | Filing | ||
| FLAC | $10.00 | 1,000,000 | Officer, Director | 1,000,000 | 2020-12-11 | Filing | |
| ALPN | $5.37 | 372,439 | Large Shareholder, Director | 2,571,450 | 2019-01-18 | Filing | |
| ETTX | $15.00 | 375,887 | Large Shareholder, Director | 1,349,953 | 2018-09-28 | Filing | |
| APTX | $16.00 | 150,000 | Large Shareholder, Director | 3,190,079 | 2018-06-25 | Filing |
Insider Trading: Sales See All